{"id":"NCT02151682","sponsor":"Gr端nenthal GmbH","briefTitle":"A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain","officialTitle":"An Open-label Trial, Enrolling Subjects Aged 6 Years to Less Than 18 Years Suffering From Pain Requiring Prolonged Release Opioid Treatment, to Evaluate the Safety and Efficacy of Tapentadol PR Versus Morphine PR, Followed by an Open-label Extension","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2015-04-29","primaryCompletion":"2017-10-18","completion":"2018-10-15","firstPosted":"2014-05-30","resultsPosted":"2019-09-12","lastUpdate":"2019-09-12"},"enrollment":73,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pain"],"interventions":[{"type":"DRUG","name":"Tapentadol prolonged release","otherNames":["Palexia速","Nucynta速","Yantil速"]},{"type":"DRUG","name":"Morphine prolonged release","otherNames":[]}],"arms":[{"label":"Morphine prolonged-release (Part 1)","type":"ACTIVE_COMPARATOR"},{"label":"Tapentadol prolonged-release (Part 1)","type":"EXPERIMENTAL"},{"label":"Tapentadol in Part 2 after Tapentadol or Morphine in Part 1","type":"EXPERIMENTAL"},{"label":"Observation Period after Tapentadol in Part 1","type":"NO_INTERVENTION"},{"label":"Observation Period after Morphine in Part 1","type":"NO_INTERVENTION"},{"label":"Observation Period after Tapentadol in Part 2","type":"NO_INTERVENTION"}],"summary":"Tapentadol has already been studied in adults. This study is needed to find out if tapentadol works and is safe to use in children and adolescents with long-term pain.","primaryOutcome":{"measure":"Number of Participants Classified as Responder (Part 1)","timeFrame":"From Day 1 up to Day 14 (End of Part 1)","effectByArm":[{"arm":"Morphine Prolonged-release (Part 1)","deltaMin":19,"sd":null},{"arm":"Tapentadol Prolonged-release (Part 1)","deltaMin":32,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0790"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":16},"locations":{"siteCount":23,"countries":["Belgium","Bulgaria","Chile","France","Germany","Hungary","Italy","Portugal","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":24},"commonTop":["Nausea","Vomiting","Headache","Constipation","Abdominal pain"]}}